MAMaria Claudia Terkelli de Assis

Maria Claudia Terkelli de Assis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Claudia Terkelli de Assis has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigation of the molecular mechanisms of action of sophorolipids in MCF-7 cells: therapeutic potential against breast cancer

    by Luiz Henrique Santana Martins, Luan Vitor Alves de Lima, Matheus Felipe da Silva, Niumaique Gonçalves da Silva, Maria Claudia Terkelli de Assis, Isabella Cristina Oliveira Carvalho, Isaura Maria Fuzzinato, Beatriz Braga Silva, Dimitri Alves da Costa, Mattheus Pizane de Azevedo Silva, et al.

    A mixture of lactonic and acidic sophorolipids exerted concentration-dependent cytotoxicity against human breast ductal adenocarcinoma (MCF-7) cells, with an IC₅₀ of 82.54 µg/mL as determined by resazurin assay. Phase-contrast microscopy revealed morphological alterations including cell swelling, loss of adhesion, and impaired membrane integrity. Flow cytometry analysis demonstrated cell cycle arrest in the S phase, mitochondrial membrane depolarization, and a predominance of necrosis-like cell death at higher concentrations. Transcriptional profiling by RT-qPCR identified overexpression of CDKN1A , GADD45A , ERN1 , and BBC3 , alongside repression of ACTB and GAPDH , indicating activation of DNA damage and stress-response pathways, endoplasmic reticulum stress, structural collapse, and metabolic dysfunction. Collectively, these findings demonstrate that sophorolipids induce mitochondrial and endoplasmic reticulum stress, culminating in homeostatic failure and cell death in MCF-7 cells, positioning these biosurfactants as promising candidates for the development of natural antiproliferative therapies.

  • Dysregulation of mTOR , GADD45a , and CDKN1A in HepG2/C3A Spheroids Treated With Ursolic Acid

    by Maria Claudia Terkelli de Assis, Luan Vitor Alves de Lima, Liana Martins de Oliveira, Matheus Felipe da Silva, Isabella Cristina Oliveira Carvalho, Isaura Maria Fuzinatto, Mário Sérgio Mantovani

    Phytochemicals are plant‐derived compounds extensively studied for the discovery and development of new drugs. Ursolic acid (UA), a pentacyclic triterpenoid phytochemical extracted from the bark and leaves of plants in the Lamiaceae family, has been the focus of research due to its antiproliferative potential, which has not yet been evaluated in tumor spheroids. This study aimed to analyze the antiproliferative effects and mechanisms of action of UA in 3D cultures (spheroids) of HepG2/C3A cells (human hepatocarcinoma). The analyses in 3D culture included average spheroid volume, genotoxicity using the comet assay, and the influence on mRNA expression, based on the cytotoxicity of UA assessed by the resazurin assay in 2D culture. The data showed that after 24 h of treatment, UA exhibited cytotoxicity at concentrations of 100 and 150 μM, reduced spheroid growth, demonstrated genotoxicity, and induced an increase in MTOR gene expression (2.38×). At 72 h, there was an upregulation of GADD45A (8.8×) and a downregulation of CDKN1A (2×). It is concluded that UA exhibits antiproliferative actions, promoting changes in the expression of genes associated with cell cycle control and DNA damage. This study has contributed to understanding the mechanism of action of this phytochemical for its therapeutic potential.